SCHEMBL16609246

SCHEMBL16609246

Nc1nc(CC(=O)Nc2ccc(CCN(CCCCO)C[C@H](O)c3ccccc3)cc2)cs1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 9/20 0.66
ADRB1 P08588 5/20 0.55
ADRB2 P07550 4/20 0.55
CYP2D6 P10635 2/20 0.52
SLC6A4 P31645 1/20 0.52
KCNH2 Q12809 1/20 0.52
CACNA1C Q13936 1/20 0.52
SCN5A Q14524 1/20 0.52
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CTPS1 P17812 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25159572 0.90 ADRB3 (0.68) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL6621610 0.86 ADRB3 (0.70) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL15994158 0.86 ADRB3 (0.70) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL16609338 0.85 ADRB3 (0.69) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL21952232 0.85 ADRB3 (0.69) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL28986806 0.84 ADRB3 (0.68) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL31361990 0.84 ADRB3 (0.68) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL28986807 0.84 ADRB3 (0.68) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL16609237 0.80 ADRB3 (0.62) ADRB3ADRB1ADRB2CYP2D6SLC6A4
SCHEMBL17209111 0.80 ADRB3 (0.62) ADRB3ADRB1ADRB2CYP2D6SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015044965-A1 A PROCESS FOR PREPARATION OF MIRABEGRON AND ALPHA CRYSTALLINE FORM THEREOF MEGAFINE PHARMA (P) LTD. (IN) 2015-04-02 WO disclosed